What is effective treatment of depression in people with epilepsy?

Epilepsy and Behavior

Volumn 6, Issue 4, 2005, Pages 520-528

  Barry, John J ^a   Jones, Jana E ^b  

^a STANFORD UNIVERSITY   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; ANTIDEPRESSANT AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; CITALOPRAM; DOXEPIN; FLUOXETINE; IMIPRAMINE; MIRTAZAPINE; NEFAZODONE; NOMIFENSINE; PAROXETINE; REBOXETINE; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TRICYCLIC ANTIDEPRESSANT AGENT;

ARTICLE; BEHAVIOR THERAPY; CLINICAL TRIAL; COGNITIVE THERAPY; COMORBIDITY; DEPRESSION; DRUG BLOOD LEVEL; DRUG METABOLISM; DRUG POTENTIATION; DRUG RESPONSE; EPILEPSY; HEALTH CARE COST; HUMAN; MAJOR DEPRESSION; OUTCOMES RESEARCH; PATHOGENESIS; QUALITY OF LIFE; RECURRENT DISEASE; RELAPSE; REMISSION; SOCIAL PSYCHOLOGY;

ANTIDEPRESSIVE AGENTS; COMORBIDITY; DEPRESSION; ENVIRONMENT; EPILEPSY; HUMANS; MODELS, PSYCHOLOGICAL;

EID: 18744372486     PISSN: 15255050     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.yebeh.2005.03.017     Document Type: Article

References (76)

1. R.M. Glass Awareness about depression: Important for all physicians JAMA 289 2003 3169-3173
2. W.F. Stewart J.A. Ricci E. Chee et al. Cost of lost productive work time among us workers with depression JAMA 289 2003 3135-3144
3. J.R.T. Davidson S.E. Meltzer-Brody The underrecognition and undertreatment of depression: What is the breadth and depth of the problem? J Clin Psychiatry 60 Suppl. 7 1999 4-9
4. R.L. Spitzer K. Kroenke Linzer et al. Health-related quality of life in primary care patients with mental disorders: Results from the PRIME_MD1000 Study JAMA 274 1995 1511-1517
5. P. Wiegartz M. Seidenberg A. Woodard et al. Co-morbid psychiatric disorder in chronic epilepsy: Recognition and etiology of depression Neurology 53 1999 3-25
6. L.S. Boylan L.A. Flint D.L. Labovitz S.C. Jackson K. Starner O. Devinsky Depression but not seizure frequency predicts quality of life in treatment-resistant epilepsy Neurology 62 2004 258-261
7. Cramer JA, Blum D, Reed M, Fanning K, for the Epilepsy Impact Project Group. The influence of comorbid depression on quality of life for people with epilepsy. Epilepsy Behav 2003;4:515-21
8. F. Gilliam Optimizing health outcomes in active epilepsy Neurology 58 8, Suppl. 5 2002 S9-S20
9. E. Johnson J.E. Jones M. Seidenberg B.P. Hermann The relative impact of anxiety, depression, and clinical seizure features on health-related quality of life in epilepsy Epilepsia 45 2004 544-550
10. Ettinger A, Reed M, Cramer J, for the Epilepsy Impact Project Group. Depression and comorbidity in community-based patients with epilepsy or asthma. Neurology 2004;63:1008-14
11. A. Ettinger P. Gibson J. Cramer et al. Prevalence of depression in persons with epilepsy, and associated findings from Epilepsy Impact Project [abstract] Epilepsia 43 Suppl. 7 2002 120
12. D.L. Evans D.S. Charney Mood disorders and medical Illness: A major public health problem Biol Psychiatry 54 2003 177-180
13. D.C. Hesdorffer W.A. Hauser J.F. Annegers G. Cascino Major depression is a risk factor for seizures in older adults Ann Neurol 47 2000 246-249
14. D.C. Hesdorffer P. Ludvigsson W.A. Hauser et al. Depression is a risk factor for epilepsy in children Epilepsia 39 1998 222A
15. W.A. Hauser D.C. Hesdorffer Psychosis, depression and epilepsy: epidemiologic considerations In: A.B. Ettinger A.M. Kanner, editors. Psychiatric issues in epilepsy: A practical guide to diagnosis and treatment 2000 Lippincott Williams & Wilkins Baltimore 7-17
16. A.M. Kanner A. Balabanov Depression and epilepsy: How closely related are they? Neurology 58 2002 S27-S39
17. R.C. Kessler K.A. McGonagle S. Zhao et al. Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States: results from the National Comorbidity Survey Arch Gen Psychiatry 51 1994 8-19
18. J.E. Jones B.P. Herman J.J. Barry F.G. Gilliam A.M. Kanner K.J. Meador Rates and risk factors for suicide, suicidal ideation, and suicide attempts in chronic epilepsy Epilepsy Behav 4 2003 S31-S38
19. R.D. Kessler G. Borges E.E. Walters Prevalence of and risk factors for lifetime suicide attempts in the National Comorbidity Survey Arch Gen Psychiatry 56 1999 617-626
20. E.K. Mościcki P. O'Carroll D.S. Rae B.Z. Locke A. Roy D.A. Regier Suicide attempts in the Epidemiologic Catchment Area Study Yale J Biol Med 18 1988 121-128
21. P.C. Jobe Common pathogenic mechanisms between depression and epilepsy: an experimental perspective Epilepsy Behav 4 2003 S14-S24
22. P.C. Jobe Current and future therapeutic opportunities in the comorbidity between the epilepsies and affective disorders Clin EEG Neurosci 35 2004 1-3
23. P.C. Jobe J.W. Dailey J.F. Wernicke A noradrenergic and serotonergic hypothesis of the linkage between epilepsy and affective disorders Crit Rev Neurobiol 13 1999 317-356
24. 1A receptor binding in patients with temporal lobe epilepsy Neurology 60 2003 749-756
25. 18F]MPPF-PET study Brain 127 2004 900-919
26. 1A receptor binding in human temporal lobe epilepsy Neurology 62 2004 1343-1351
27. Y. Shirayama A.C. Chen S. Nakagawa D.S. Russell R.S. Duman Brain-derived neurotrophic factor produces antidepressant effects in behavioral models of depression J Neurosci 22 2002 3251-3261
28. H. Hećimović J.D. Goldstein Y.I. Sheline F.G. Gilliam Mechanisms of depression in epilepsy from a clinical perspective Epilepsy Behav 4 2003 S25-S30
29. H.K. Manji W.C. Drevets D.S. Charney The cellular neurobiology of depression Nat Med 7 2001 541-547
30. R.S. Duman G.R. Heninger E.J. Nestler A molecular and cellular theory of depression Arch Gen Psychiatry 54 1997 597-606
31. Y.I. Sheline M.H. Gado H.C. Kraemer Untreated depression and hippocampal volume loss Am J Psychiatry 160 2003 1516-1518
32. A.M. Kanner Is major depression a neurological disorder with psychiatric symptoms? Epilepsy Behav 2004 636-644
33. F.G. Gilliam J. Santos V. Vahle J. Carter K. Brown H. Hecimovic Depression in epilepsy: Ignoring clinical expression of neuronal network dysfunction? Epilepsia 45 Suppl. 2 2004 28-33
34. B.S. McEwen Mood disorders and allostatic load Biol Psychiatry 54 2003 200-207
35. W.J. Katon Clinical and health services relationships between major depression, depressive symptoms, and general medical illness Biol Psychiatry 54 2003 216-226
36. B.P. Hermann M. Seidenberg B. Bell Psychiatric comorbidity in chronic epilepsy: Identification, consequences, and treatment of major depression Epilepsia 41 2000 S31-S41
37. B.P. Hermann S. Whitman Neurobiological, psychosocial, and pharmacological factors underlying interictal psychopathology in epilepsy In: D.B. Smith D.M. Treiman M.R. Trimble, editor. Advances in neurology, Vol. 55: Neurobehavioral problems in epilepsy 1991 Raven Press New York
38. D. Roth K.T. Goode V.L. Williams et al. Physical exercise, stressful life experience, and depression in adults with epilepsy Epilepsia 35 1994 1248-1255
39. L.N. Robins B.Z. Locke D.A. Regier An overview of psychiatric disorders in America In: L.N. Robins D.A. Regier, editors. Psychiatric disorders in America: The Epidemiologic Catchment Area Study 1991 Free Press New York 328-366
40. M.B. Keller W. Harrison J.A. Fawcett et al. Treatment for chronic depression with sertraline and imipramine: Preliminary blinded response rate and high rates of undertreatment in the community Psychopharmacol Bull 31 1995 205-212
41. R. Hirschfeld M. Keller Panico et al. The National Depressive and Manic Depressive Association consensus statement on the undertreatment of depression JAMA 55 1999 1-10
42. J. McQuaid M. Stein C. Laffaye et al. Depression in a primary care clinic: The prevalence and impact of an unrecognized disorder J Affect Disord 55 1999 1-10
43. A. Ettinger D.M. Weisbrot E.E. Nolan et al. Symptoms of depression and anxiety in pediatric epilepsy patients Epilepsia 39 1998 595-599
44. Jones J, Hermann BP, Barry J, Gilliam F, Kanner A, Meador K. Clinical assessment of Axis 1 psychiatric morbidity in chronic epilepsy: A multicenter investigation. J Neuropsychiatry Clin Neurosci, in press
45. D.V. Sheehan Y. Lecrubier K.H. Sheehan et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): The development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10 J Clin Psychiatry 59 Suppl. 20 1998 22-33
46. First MB, Spitzer RL, Gibbon M, Williams J. Structured clinical interview for DSM-V-TR Axis I disorders: Non-patient edition (SCI-I/NP-2/ 2001 Revision). New York: Biometrics Research Department; 2001
47. A.T. Beck R.A. Steer G.K. Brown Beck Depression Inventory manual 2nd ed 1996 Psychological Corp. San Antonio
48. L.S. Radloff The CES-D Scale: A self-report depression scale for research in the general population J Appl Psychol Measure 1 1977 385-401
49. J. Unutzer D.L. Patrick T. Marmon G.E. Simon W.J. Katon Depressive symptoms and mortality in a prospective study of 2,558 older adults Am J Geriatr Psychiatry 10 2002 521-530
50. S.H. Kennedy R.W. Lam D.J. Nutt M.E. Thase Treating depression effectively 2004 Martin Dunitz New York
51. A.A. Nierenberg L.M. DeCecco Definitions of antidepressant treatment response, remission, nonresponse, partial response, and other relevant outcomes: A focus on treatment-resistant depression J Clin Psychiatry 62 Suppl. 16 2001 5-9
52. J.F. Greden Unmet need: What justifies the search for a new antidepressant? J Clin Psychiatry 63 Suppl. 2 2002 3-7
53. M. Fava A.J. Rush M.H. Trivedi et al. Background and rationale for the sequenced treatment alternatives to relieve depression (STAR*D) study Psychiatr Clin North Am 26 2003 457-494
54. L.L. Judd H.S. Akiskal J.D. Maser et al. Major depressive disorder: prospective study of residual subthreshold depressive symptoms as predictor of rapid relapse J Affect Disord 50 1998 97-108
55. E.S. Paykel R. Ramana Z. Cooper H. Hayhurst J. Kerr A. Barocka Residual symptoms after partial remission: An important outcome in depression Psychol Med 25 1995 1171-1180
56. L.L. Judd P.J. Schettler H.S. Akiskal The prevalence, clinical relevance, and public health significance of subthreshold depressions Psychiatr Clin North Am 25 2002 685-698
57. I.W. Miller G.I. Keitner A.F. Schatzberg et al. The treatment of chronic depression. Pt 3: Psychosocial functioning before and after treatment with sertraline or imipramine J Clin Psychiatry 59 1998 608-619
58. M.B. Keller J.P. McCullough D.N. Klein et al. A comparison of nefazodone, the cognitive behavioral-analysis system of psychotherapy, and their combination for the treatment of chronic depression N Engl J Med 342 2000 1462-1470
59. G.A. Fava C. Rafanelli S. Grandi et al. Six-year outcome for cognitive behavioral treatment of residual symptoms in major depression Am J Psychiatry 155 1998 1443-1445
60. J.I. Victoroff F. Benson S.T. Grafton J. Engel J.C. Mazziotta Depression in complex partial seizures: Electroencephalography and cerebral metabolic correlates Arch Neurol 51 1994 155-163
61. A.M. Kanner A.M. Kozak M. Frey The use of sertraline in patients with epilepsy: Is it safe? Epilepsy Behav 1 2000 100-105
62. D. Blumer J.J. Zielinski Pharmacologic treatment of psychiatric disorders associated with epilepsy J Epilepsy 1 1988 135-150
63. D. Blumer Dysphoric disorders and paroxysmal affects: Recognition and treatment of epilepsy-related psychiatric disorders Harv Rev Psychiatry 8 2000 8-17
64. D. Blumer A.G. Herzog J. Himmelhoch et al. To what extent do premenstrual and interictal dysphoric disorder overlap? Significance for therapy J Affect Disord 48 1998 215-225
65. A.M. Kanner J.J. Barry Is the psychopathology of epilepsy different from that of nonepileptic patients? Epilepsy Behav 2 2001 170-186
66. M.M. Robertson M.R. Trimble The treatment of depression in patients with epilepsy: A double-blind trial J Affect Disord 9 1985 127-136
67. L.M. Ojemann P.N. Friel W.J. Trejo D.L. Dudley Effect of doxepin on seizure frequency in depressed epileptic patients Neurology 33 1983 646-648
68. L.M. Ojemann C. Baugh-Bookman D.L. Dudley Effect of psychotropic medications on seizure control in patients with epilepsy Neurology 37 1987 1525-1527
69. J. Hovorka E. Herman I. Nemcová Treatment of interictal depression with citalopram in patients with epilepsy Epilepsy Behav 1 2000 444-447
70. L.M. Specchio I. Alfonso S. Nicola et al. Citalopram as treatment of depression in people with epilepsy Clin Neuropharmacol 27 2004 133-136
71. Handbook of psychiatric measures, Washington, DC: APA; 2000. p. 531-3
72. K.U. Kühn B.B. Quednow M. Thiel et al. Antidepressant treatment in patients with temporal lobe epilepsy and major depression : A prospective study with three different antidepressants Epilepsy Behav 4 2003 674-679
73. D. Blumer Antidepressant and double antidepressant treatment for the affective disorder of epilepsy J Clin Psychiatry 58 1997 3-11
74. J.C. Nelson Augmentation strategies with serotonin-noradrenergic combinations J Clin Psychiatry 59 Suppl. 5 1998 65-69
75. A.F. Schatzberg J.O. Cole C. DeBattista Augmentation strategies for treatment-resistant disorders Manual of clinical psychopharmacology 4th ed 2003 APA Press Washington, DC 437-480
76. R.J. Boland M.B. Keller Treatment of depression In: A.F. Schatzberg D.B. Nemeroff, editors. Textbook of psychopharmacology 3rd ed 2004 American Psychiatric Press, Inc. Washington, DC 847-864